rajneesh singh
☆    

2011-06-13 12:14
(5085 d 14:23 ago)

Posting: # 7112
Views: 5,688
 

 Reference Scaled Design [RSABE / ABEL]

Dear All,

Please any one suggest what are the main differences of Analysis for EMEA and USFDA Reference Scaled Study.

For USFDA, The 95% upper confidence bound for Square(YT -YR)-theta* within subject variability <=0
And the point estimate of the Test/Reference geometric mean ratio must fall within [0.80, 1.25]
For EMEA [U,L]= Exp[+/- k.swr] where k= 0.760,and swr = within subject variability of ln transformed of Cmax. CV % = 100*Exp(squre swr)-1 > 30% then our acceptance limit can be wide according to variability.

Is above main difference between USFDA and EMEA approach for reference scaled.

if else any other differences in approaches please suggest me. and how to do the analysis and any other criteria or any specification for regulatory also please suggest.


Thanks & Regards,
RS


Edit: Category changed. [Helmut]
GSTATS
☆    
Homepage
India,
2011-06-13 13:06
(5085 d 13:31 ago)

@ rajneesh singh
Posting: # 7113
Views: 4,754
 

 Reference Scaled Design

Dear RS,

❝ Please any one suggest what are the main differences of Analysis for EMEA and USFDA Reference Scaled Study.


I feel the main difference between the approaches recommended by EMA and FDA for reference scale study is the difference in regulatory constant used for scaling i.e For FDA swo=0.25 and for EMA swo=0.2936.

For complete disscussion on differences you should go through the thread given below:
Thread

Regards,
GSTATS

Let Noble Thoughts come from Every Side: RIG VEDA
rajneesh singh
☆    

2011-06-17 11:41
(5081 d 14:56 ago)

@ GSTATS
Posting: # 7146
Views: 4,622
 

 Reference Scaled Design

Dear Gstat,

Please clarify, for reference Scale Design in USFDA submission :

Our BE criteria: Upper bound of 95% CI of (µT-µR)2 – θ σ2wr <= 0

Where θ = scaled average BE limit and θ = (ln Δ)2/ σ2wo Where σwo = 0.25

is that correct or not.:confused:

Thanks & Regards,
RS


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
GSTATS
☆    
Homepage
India,
2011-06-17 18:17
(5081 d 08:20 ago)

@ rajneesh singh
Posting: # 7151
Views: 4,648
 

 Reference Scaled Design

Dear RS,


❝ Our BE criteria: Upper bound of 95% CI of (µT-µR)2 – θ σ2wr <= 0


❝ Where θ = scaled average BE limit and θ = (ln Δ)2/ σ2wo Where σwo = 0.25


❝ is that correct or not.:confused:


Yes, that is correct.

Regards,
GSTATS
www.gstatsolutions.com

Let Noble Thoughts come from Every Side: RIG VEDA
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
102 visitors (0 registered, 102 guests [including 63 identified bots]).
Forum time: 02:37 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5